Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fu-Min Shen

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Yi Chuan = Hereditas|September 2, 2005
[Studies of genetic polymorphisms of ADH2 and ALDH2 among the Han population in Luoyang China]Zhu-mei Zhang, Cha-zhen Liu, Jian-chao Bian, et al.
Cancer Research|August 9, 2003
Susceptibility to aflatoxin B1-related primary hepatocellular carcinoma in mice and humansKatherine A McGlynn, Kent Hunter, Thomas LeVoyer, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 6, 2007
Blood folate levels and risk of liver damage and hepatocellular carcinoma in a prospective high-risk cohortTania M Welzel, Hormuzd A Katki, Lori C Sakoda, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Yi Chuan = Hereditas|September 2, 2005
[Studies of genetic polymorphisms of ADH2 and ALDH2 among the Han population in Luoyang China]Zhu-mei Zhang, Cha-zhen Liu, Jian-chao Bian, et al.
Cancer Research|August 9, 2003
Susceptibility to aflatoxin B1-related primary hepatocellular carcinoma in mice and humansKatherine A McGlynn, Kent Hunter, Thomas LeVoyer, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 6, 2007
Blood folate levels and risk of liver damage and hepatocellular carcinoma in a prospective high-risk cohortTania M Welzel, Hormuzd A Katki, Lori C Sakoda, et al.
Pageof 2